Hemalatha Bhamidi, DO
Internal Medicine · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital-Santa Rosa. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bhamidi’s office at (707) 393-4000 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-Santa RosaSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.587, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-Santa Rosa
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 0 worse of 1 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.587 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.12) · 102 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.47 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 13.4 · 225 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 3,003 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 467 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.1 to 0.53) · 474 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.37 (0.77 to 5.96) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.29 (0.57 to 4.01) · 68 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.09 (0.56 to 3.61) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.5 (0 to 1.7) · 344 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 121 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.591 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.54 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.391 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.362 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 123 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.9 · 592 cases | None | Jul 2023 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 530 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.8 · 120 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 200 cases | None | Jul 2023 – Jun 2025 |
What patients said (2,003 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$1,689
Medicare paid this office $1,689 for 15 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
15 Original Medicare patients in 2024. Average age 70 · Health risk score 2.35. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 73%.
The office billed $4,940, Medicare allowed $2,120 and paid $1,689; for 23 services of 4 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 15 | 23 | 70 | 2.35 | $4,940 | $1,689 |
| 2023 | 203 | 469 | 74 | 1.06 | $183,497 | $49,138 |
| 2022 | 224 | 473 | 74 | 1.10 | $169,097 | $49,244 |
| 2021 | 24 | 33 | 74 | 0.93 | $12,275 | $3,446 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 111 | $18,883 | $104 |
| New patient visit (45+ min) | 54 | $7,072 | $131 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 35 | $5,305 | $152 |
| Short return visit (20+ min) | 54 | $4,931 | $81 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 15 | $4,229 | $282 |
| Long return visit (40+ min) | 20 | $3,143 | $131 |
| Influenza vaccine split virus, preservative free | 17 | $1,223 | $72 |
| Administration of influenza virus vaccine | 15 | $539 | $36 |
| Administration of pneumococcal vaccine | 15 | $539 | $36 |
2022: 8 services
| Return visit (30+ min) | 84 | $17,892 | $118 |
| New patient visit (45+ min) | 60 | $8,772 | $146 |
| Long return visit (40+ min) | 21 | $4,830 | $167 |
| Influenza vaccine split virus, preservative free | 69 | $4,729 | $69 |
| New patient visit (60+ min) | 16 | $3,252 | $203 |
| Administration of influenza virus vaccine | 70 | $2,606 | $37 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $2,058 | $158 |
| Short return visit (20+ min) | 24 | $1,967 | $82 |
2021: 1 service
| Return visit (30+ min) | 12 | $1,449 | $121 |
Drugs they prescribed that Part D paid
$29,010
Pharmacies billed $29,010 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
340 generic and fewer than 11 brand-name prescriptions · $29,010 in drug cost · 86 antibiotic prescriptions to 66 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cefpodoxime Proxetil | 29 | $600 | $21 |
| Pantoprazole | 17 | $195 | $11 |
| Atorvastatin | 17 | $165 | $10 |
| Levothyroxine | 13 | $135 | $10 |
| Lisinopril | 11 | $119 | $11 |
Year by year
| 2024 | 396 | 192 | None | None | $29,010 |
| 2023 | 1,129 | 255 | 2% (25) | 9% | $72,817 |
| 2022 | 580 | 232 | 3% (16) | None | $23,132 |
| 2021 | 63 | 43 | None | None | $1,839 |
| 2019 | 27 | 12 | None | None | $544 |
| 2018 | 41 | 12 | None | None | $3,691 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Rosuvastatin | 63 | $1,412 | $22 |
| Atorvastatin | 77 | $1,162 | $15 |
| Levothyroxine | 65 | $781 | $12 |
| Amlodipine Besylate | 55 | $574 | $10 |
| Albuterol Sulfate Hfa | 15 | $552 | $37 |
| Losartan | 36 | $514 | $14 |
| Gabapentin | 24 | $507 | $21 |
| Lisinopril | 41 | $434 | $11 |
| Tamsulosin | 11 | $373 | $34 |
| Simvastatin | 12 | $293 | $24 |
| Metoprolol | 15 | $271 | $18 |
| Fluoxetine | 19 | $262 | $14 |
| Metformin | 22 | $261 | $12 |
| Trazodone | 33 | $258 | $8 |
| Zolpidem | 25 | $250 | $10 |
| Lisinopril-Hydrochlorothiazide | 11 | $215 | $20 |
| Alendronate | 13 | $179 | $14 |
| Metformin Hcl Er | 16 | $138 | $9 |
| Lovastatin | 11 | $136 | $12 |
| Omeprazole | 15 | $123 | $8 |
| Hydrochlorothiazide | 21 | $68 | $3 |
| Alprazolam | 18 | $41 | $2 |
2022: 14 drugs
| Rosuvastatin | 37 | $988 | $27 |
| Levothyroxine | 28 | $418 | $15 |
| Gabapentin | 17 | $379 | $22 |
| Atorvastatin | 28 | $261 | $9 |
| Amlodipine Besylate | 35 | $252 | $7 |
| Omeprazole | 12 | $199 | $17 |
| Carvedilol | 12 | $198 | $17 |
| Zolpidem | 15 | $135 | $9 |
| Lisinopril | 19 | $120 | $6 |
| Alprazolam | 17 | $91 | $5 |
| Metformin | 11 | $90 | $8 |
| Trazodone | 12 | $58 | $5 |
| Losartan | 12 | $57 | $5 |
| Hydrochlorothiazide | 12 | $41 | $3 |
Money from drug and device companies
$26 in 2019
A payment is not proof that care is biased.
| Rigel Pharmaceuticals | Tavalisse | $26 | 1 payment
|
See the published payment
| Rigel Pharmaceuticals | Meals · 2019-09-27 | Tavalisse | $26 |
Professional record
- NPI
- 1225533219
- Licence
- CA 20A19121
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 14251 Winchester Blvd # 200, Los Gatos, CA, 95032
- NPI first listed
- 2018-03-29
- NPI last updated
- 2021-10-04
- NPI record certified
- 2021-10-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1701 W Charleston Blvd Ste 230, Las Vegas, NV, 89102